Antibiotic resistance (AMR) is no longer a future concern. It is a present threat in many parts of Africa, including the Horn. Recent research highlights that in low- and middle-income countries, fewer than 7% of people with severe drug-resistant infections receive the correct antibiotics. This gap in access not only increases mortality, but also accelerates the spread of resistance by allowing suboptimal or partial treatments to persist.

In East African settings, evidence from hospital studies reveals high levels of resistance even in first- and second-line antibiotics. For example, in Djibouti, Gram-negative bacteria isolated from clinical samples displayed alarmingly high resistance rates to third-generation cephalosporins; organisms like E. coli showed over 30-40% resistance to commonly used antibiotics.

Meanwhile, hospital wastewater across West Africa also emerges as a reservoir for resistance genes, underscoring environmental pathways that traditional antibiotic stewardship must address.

The situation demands a multifaceted strategy. First among these is ensuring equitable access to quality antibiotics—so that required medicines are available, affordable, and used appropriately. Regulatory oversight, clearer prescribing practices, diagnostic capacity, and community education all matter. Second, environmental and infrastructure components, such as proper hospital waste management to prevent antibiotic residues from leaking into water systems, must be strengthened. Third, partnerships with researchers, local clinics, and public health authorities are critical for surveillance, rapid identification of resistance patterns, and rapid response when outbreaks occur.

For Bidhaan Pharmaceutical, this means not only supplying appropriate antibiotic formulations but also investing in quality control, collaborating with laboratories for antibiotic susceptibility testing, and contributing to education campaigns. Doing so helps protect public health, sustain the effectiveness of existing treatments, and build trust in healthcare systems that rely on antibiotics to save lives.